Page last updated: 2024-08-24

dexmedetomidine and Osteosarcoma

dexmedetomidine has been researched along with Osteosarcoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, L; Cheng, J; Gao, J; Jin, S; Le, C; Li, N; Liu, H; Yan, R1
Chen, X; Wang, X; Xiao, J; Xu, Y1

Other Studies

2 other study(ies) available for dexmedetomidine and Osteosarcoma

ArticleYear
Dexmedetomidine inhibits cell malignancy in osteosarcoma cells via miR-520a-3p-YOD1 interactome.
    Biochemical and biophysical research communications, 2021, 03-05, Volume: 543

    Topics: Analgesics, Non-Narcotic; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dexmedetomidine; Endopeptidases; Humans; MicroRNAs; Osteosarcoma; Signal Transduction; Thiolester Hydrolases

2021
[ARTICLE WITHDRAWN] Dexmedetomidine Inhibits Osteosarcoma Cell Proliferation and Migration, and Promotes Apoptosis by Regulating miR-520a-3p.
    Oncology research, 2018, 04-10, Volume: 26, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Apoptosis; Biomarkers, Tumor; Bone Neoplasms; Cell Movement; Cell Proliferation; Dexmedetomidine; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Osteosarcoma; Tumor Cells, Cultured

2018